Integrated urologic diagnostics

Integrated urologic diagnostics for clearer clinical decisions.

BioVantra brings together cytomolecular testing, cancer estimation and mapping, and digital pathology and reporting support in a structured, prostate-focused workflow for urologists and other clinicians involved in the diagnosis, surveillance, and treatment planning of prostate and bladder cancer.

Focus
Urologic, prostate-led
Built for
Urology practices & clinicians
Delivery
Structured reporting
01 · Core services

A focused portfolio
for urologic diagnostics.

Four offerings that work on their own or together — from testing through structured report delivery.

Service 01

Integrated Prostate Cytomolecular Testing

A prostate-focused diagnostic service that integrates cytologic and molecular information into a more structured and clinically useful report.

Learn more
Service 02

Prostate Cancer Estimation and Mapping

A structured interpretation service designed to clarify cancer extent, lesion distribution, and treatment-planning relevance.

Learn more
Service 03

Integrated Urothelial Cytomolecular Testing

A non-invasive diagnostic offering that combines urine cytology and molecular analysis in a single integrated report to support bladder cancer detection and surveillance.

Learn more
Service 04

Digital Pathology and Reporting Support

Digital pathology and synoptic reporting support intended to improve diagnostic clarity, consistency, and communication.

Learn more
02 · Why BioVantra

Prostate-focused,
integrated by design.

Our work is shaped around one clinical area. That focus shows up in how our tests, estimation tools, and reporting come together for urologists and other healthcare professionals involved in the diagnosis, surveillance, and treatment planning of prostate and bladder cancer.

  • A

    Prostate-focused diagnostic expertise

    Our work is shaped around prostate cancer diagnosis, alongside bladder cancer detection and surveillance through urothelial cytomolecular testing.

  • B

    Integrated interpretation across modalities

    Cytologic, molecular, and pathology information are brought together into one coherent diagnostic view rather than reported in isolation.

  • C

    Clearer structured reporting

    Synoptic formats and consistent terminology are used to present findings in a way that is easier to read, compare, and act on.

  • D

    Clinically and operationally useful

    Outputs are designed to fit into how urologists and other clinicians involved in diagnosis and treatment already work, from testing through structured report delivery.

03 · Resources & clinical insights

Reading for urology
and clinical teams.

A short selection of materials explaining our approach. The full library lives on the Resources page.

Connect with BioVantra

Talk to us about integrated urologic diagnostics.

We work with urology practices and clinical teams involved in the diagnosis and treatment of prostate and bladder cancer. Share a little about your setting and a member of our team will follow up.

Existing client? Access diagnostic reports and case history through the Client Portal
Fax(352) 671-2737
Address9401 SW Highway 200
STE 502
Ocala, FL 34481-9650